Skip to main content
Top
Published in: Journal of Cancer Survivorship 2/2009

01-06-2009

Cancer survivors need evidence on how to optimize physical function

Author: Michael Feuerstein

Published in: Journal of Cancer Survivorship | Issue 2/2009

Login to get access

Excerpt

About two months ago I was walking in Georgetown on a perfectly sunny Sunday afternoon. The sidewalk I was on had no uneven sections, and it was dry with no ice or snow. Suddenly, I was falling forward. I attempted to catch myself and just could not coordinate my legs to stop the fall. I used my right arm and shoulder to break the fall and the sidewalk won out. As I sat up on the sidewalk I was in pain and found I could not move my arm. I decided I should to drive to an ER. After the X-ray and it was clear that I didn’t break anything, I went home. After the fall I thought that perhaps I should have an MRI of my brain because I, like other brain tumor survivors, know the tumor can recur with no other fanfare than the occurrence of a symptom. …
Literature
2.
go back to reference Egger M, Smith GD, Altman DG. Systematic reviews in health care: meta-analysis in context. 2nd ed. London: BMJ Books; 2001. Egger M, Smith GD, Altman DG. Systematic reviews in health care: meta-analysis in context. 2nd ed. London: BMJ Books; 2001.
Metadata
Title
Cancer survivors need evidence on how to optimize physical function
Author
Michael Feuerstein
Publication date
01-06-2009
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 2/2009
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-009-0090-5

Other articles of this Issue 2/2009

Journal of Cancer Survivorship 2/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine